Smolen JS, Genovese MC, Takeuchi T, Hyslop DL, Macias WL, Rooney T, et al. Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years median time in treatment. J Rheumatol 2019;46:7–18.
In Table 1, Phase II, NCT01469013 is mentioned twice. The second occurrence is unnecessary.
In the Results section, page 9, last …